Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 95

1.

Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study.

Navarro-Peñalver M, Perez-Martinez MT, Gómez-Bueno M, García-Pavía P, Lupón-Rosés J, Roig-Minguell E, Comin-Colet J, Bayes-Genis A, Noguera JA, Pascual-Figal DA.

J Cardiovasc Pharmacol Ther. 2018 Jan 1:1074248418784020. doi: 10.1177/1074248418784020. [Epub ahead of print]

PMID:
29929385
2.

Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population.

Mohamed-Salem L, Santos-Mateo JJ, Sanchez-Serna J, Hernández-Vicente Á, Reyes-Marle R, Castellón Sánchez MI, Claver-Valderas MA, Gonzalez-Vioque E, Haro-Del Moral FJ, García-Pavía P, Pascual-Figal DA.

Int J Cardiol. 2018 Jun 6. pii: S0167-5273(18)32651-2. doi: 10.1016/j.ijcard.2018.06.006. [Epub ahead of print]

PMID:
29903517
3.

Genetic Etiology for Alcohol-Induced Cardiac Toxicity.

Ware JS, Amor-Salamanca A, Tayal U, Govind R, Serrano I, Salazar-Mendiguchía J, García-Pinilla JM, Pascual-Figal DA, Nuñez J, Guzzo-Merello G, Gonzalez-Vioque E, Bardaji A, Manito N, López-Garrido MA, Padron-Barthe L, Edwards E, Whiffin N, Walsh R, Buchan RJ, Midwinter W, Wilk A, Prasad S, Pantazis A, Baski J, O'Regan DP, Alonso-Pulpon L, Cook SA, Lara-Pezzi E, Barton PJ, Garcia-Pavia P.

J Am Coll Cardiol. 2018 May 22;71(20):2293-2302. doi: 10.1016/j.jacc.2018.03.462.

4.

Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction.

Asensio-Lopez MDC, Lax A, Fernandez Del Palacio MJ, Sassi Y, Hajjar RJ, Pascual-Figal DA.

Transl Res. 2018 Apr 23. pii: S1931-5244(18)30058-6. doi: 10.1016/j.trsl.2018.04.004. [Epub ahead of print]

PMID:
29753686
5.

Cardiac Sympathetic Innervation and Appropriate Therapies in Patients With an Implantable Cardioverter-Defibrillator in Primary Prevention.

Navarro-Peñalver M, Mohamed-Salem L, Domínguez F, de Haro-Del Moral FJ, Fernández-Lozano I, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2018 Apr 9. pii: S1885-5857(18)30087-2. doi: 10.1016/j.rec.2018.01.014. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
29650449
6.

Analysis of Hospitalization Trends for Heart Failure in the Health Registries of Different Autonomous Communities.

Fernández Gassó ML, Hernando-Arizaleta L, Palomar Rodríguez JA, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):128-129. doi: 10.1016/j.rec.2017.09.005. Epub 2017 Nov 27. English, Spanish. No abstract available.

PMID:
29191781
7.

Neprilysin and Heart Failure: A "Sympathetic" Relationship?

Pascual-Figal DA.

J Am Coll Cardiol. 2017 Oct 24;70(17):2154-2156. doi: 10.1016/j.jacc.2017.09.003. No abstract available.

PMID:
29050563
8.

Trends, causes and timing of 30-day readmissions after hospitalization for heart failure: 11-year population-based analysis with linked data.

Fernandez-Gasso L, Hernando-Arizaleta L, Palomar-Rodríguez JA, Abellán-Pérez MV, Pascual-Figal DA.

Int J Cardiol. 2017 Dec 1;248:246-251. doi: 10.1016/j.ijcard.2017.07.094. Epub 2017 Aug 4.

PMID:
28801153
9.

Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72 H in an Experimental Rat Model of Acute Myocardial Infarction.

Sanchez-Mas J, Lax A, Asensio-Lopez MC, Lencina M, Fernandez-Del Palacio MJ, Soriano-Filiu A, de Boer RA, Pascual-Figal DA.

J Cardiovasc Transl Res. 2017 Dec;10(5-6):460-469. doi: 10.1007/s12265-017-9761-1. Epub 2017 Jul 17.

PMID:
28718055
10.

Acute heart failure and biomarkers: time also matters, don't relax.

Pascual-Figal DA.

Eur J Heart Fail. 2017 Aug;19(8):1011-1013. doi: 10.1002/ejhf.880. Epub 2017 May 25. No abstract available.

11.

Short-term Serial Measurement of Galectin-3 in Hospitalized Patients With Acute Heart Failure.

Sánchez-Serna J, Pérez-Martínez MT, Asensio-López MC, Casas T, Noguera JA, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2018 May;71(5):401-402. doi: 10.1016/j.rec.2017.03.013. Epub 2017 May 1. English, Spanish. No abstract available.

PMID:
28473265
12.

Trends and Characteristics of Hospitalization for Heart Failure in a Population Setting From 2003 to 2013.

Fernández Gassó ML, Hernando-Arizaleta L, Palomar-Rodríguez JA, Soria-Arcos F, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2017 Sep;70(9):720-726. doi: 10.1016/j.rec.2017.03.001. Epub 2017 Mar 28. English, Spanish.

PMID:
28363708
13.

Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.

Pascual-Figal DA, Ferrero-Gregori A, Gomez-Otero I, Vazquez R, Delgado-Jimenez J, Alvarez-Garcia J, Gimeno-Blanes JR, Worner-Diz F, Bardají A, Alonso-Pulpon L, Gonzalez-Juanatey JR, Cinca J; MUSIC and REDINSCOR I research groups.

Int J Cardiol. 2017 Aug 1;240:265-270. doi: 10.1016/j.ijcard.2017.03.032. Epub 2017 Mar 9.

PMID:
28318662
14.

Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure.

Aimo A, Vergaro G, Ripoli A, Bayes-Genis A, Pascual Figal DA, de Boer RA, Lassus J, Mebazaa A, Gayat E, Breidthardt T, Sabti Z, Mueller C, Brunner-La Rocca HP, Tang WH, Grodin JL, Zhang Y, Bettencourt P, Maisel AS, Passino C, Januzzi JL, Emdin M.

JACC Heart Fail. 2017 Apr;5(4):287-296. doi: 10.1016/j.jchf.2016.12.016. Epub 2017 Feb 8.

15.

Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure.

Gómez-Otero I, Ferrero-Gregori A, Varela Román A, Seijas Amigo J, Pascual-Figal DA, Delgado Jiménez J, Álvarez-García J, Fernández-Avilés F, Worner Diz F, Alonso-Pulpón L, Cinca J, Gónzalez-Juanatey JR; Red Española de Insuficiencia Cardiaca researchers (REDINSCOR II).

Rev Esp Cardiol (Engl Ed). 2017 May;70(5):338-346. doi: 10.1016/j.rec.2016.11.016. Epub 2016 Dec 21. English, Spanish.

PMID:
28011188
16.

The TBX1 Transcription Factor in Cardiac Remodeling After Myocardial Infarction.

Sánchez-Más J, Lax A, Asensio-López MC, Fernández-Del Palacio MJ, Caballero L, Navarro-Peñalver M, Pérez-Martínez MT, Gimeno-Blanes JR, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2016 Nov;69(11):1042-1050. doi: 10.1016/j.rec.2016.04.033. Epub 2016 Jul 12. English, Spanish.

PMID:
27422448
17.

Usefulness of the Hepatocyte Growth Factor as a Predictor of Mortality in Patients Hospitalized With Acute Heart Failure Regardless of Ejection Fraction.

Pérez-Calvo JI, Morales-Rull JL, Gimeno-Orna JA, Lasierra-Díaz P, Josa-Laorden C, Puente-Lanzarote JJ, Bettencourt P, Pascual-Figal DA.

Am J Cardiol. 2016 Aug 15;118(4):543-9. doi: 10.1016/j.amjcard.2016.05.048. Epub 2016 May 30.

PMID:
27338207
18.

Natriuretic Peptides: Consensus Call for Use.

Pascual Figal DA, Casademont J, Lobos JM, Piñera P, Bayes-Genis A, Ordóñez Llanos J, González-Juanatey JR.

Rev Esp Cardiol (Engl Ed). 2016 Sep;69(9):817-9. doi: 10.1016/j.rec.2016.03.015. Epub 2016 May 25. English, Spanish. No abstract available.

PMID:
27236277
19.

Consensus document and recommendations on the use of natriuretic peptides in clinical practice.

Pascual-Figal DA, Casademont J, Lobos JM, Piñera P, Bayés-Genis A, Ordóñez-Llanos J, González-Juanatey JR.

Rev Clin Esp. 2016 Aug-Sep;216(6):313-22. doi: 10.1016/j.rce.2016.02.008. Epub 2016 Mar 30. English, Spanish.

PMID:
27039260
20.

Reformulated meat products protect against ischemia-induced cardiac damage.

Asensio-Lopez MC, Lax A, Sanchez-Mas J, Avellaneda A, Planes J, Pascual-Figal DA.

Food Funct. 2016 Feb;7(2):992-1001. doi: 10.1039/c5fo01189b.

PMID:
26751429

Supplemental Content

Loading ...
Support Center